Skip to main content
. 2018 Oct 17;3(10):13343–13353. doi: 10.1021/acsomega.8b01260

Table 1. IC50 (μM ± SD) of the Studied Compounds (1–4) against HeLa Cancer Cells, HS-5 and MRC-5 Fibroblasts.

complex IC50 (μM ± SD) in HeLa cells IC50 (μM ± SD) in HS-5 cells IC50 (μM ± SD) in MRC-5 cells
1 1.010 ± 0.020 0.120 ± 0.010 0.135 ± 0.005
2 0.967 ± 0.017 0.105 ± 0.005 0.115 ± 0.005
3 0.973 ± 0.073 0.105 ± 0.005 0.120 ± 0.010
4 0.975 ± 0.025 0.094 ± 0.006 0.110 ± 0.010